Canadian Cardiovascular Society

CCS Research Awards

BMS-Pfizer AF Research Award

Sponsored by the BMS-Pfizer alliance, the AF (Atrial Fibrillation) Research Awards support excellence in AF research and support promising Canadian early career researchers with an interest in AF.

Application deadline extended: Monday, April 12, 2021 at 11:59 p.m. EST


CCS/Pfizer ATTR-CM Research Fellowship Award

This is a salary award where the purpose is to foster the growth of peer-reviewed Canadian research in the area of Transthyretin Amyloid Cardiomyopathy (ATTR-CM), with a focus on excellence and support for early career Canadian researchers familiar with diagnosing and treating patients with ATTR-CM who are looking to establish an independent research career.

Application deadline extended: Monday, April 12, 2021 at 11:59 p.m. EST


CCS-Bayer Resident Vascular Award

The CCS − Bayer Resident Vascular Award is open to Canadian clinical trainees (PGY 4-6) undertaking a research project on any topic related to thrombosis, anticoagulation, stroke or atrial fibrillation — particularly research that has the potential to advance knowledge about or improve the care of patients at risk for vascular thrombotic or embolic events.

Application deadline: TBD


CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award

This Award is intended for Canadian clinical residents (PGY 4-6), or PhDs and MDs who are within five years of their first faculty appointment at a Canadian academic institution, for a research project on any topic related to cardiometabolic disease.

Applications deadline: TBD


CCS COVID-19 Challenge for Canada Initiative (CCS-C3I)

As the prevalence and outcomes of cardiovascular complications of COVID-19 remain poorly understood and uncharacterized, the aim of C3I  is to empower the CCS clinician-scientist community to be prepared to harness emerging large-scale funds. By fostering multisite cardiovascular research across Canada, our CV community will be at the forefront of readiness for large-scale, CVD-related COVID-19 disease initiatives.

Application deadline: TBD

Back to top